Cost-Utility and Cost-Effectiveness Analyses of Face-to-Face Versus Telephone-Based Nonpharmacologic Multidisciplinary Treatments for Patients With Generalized Osteoarthritis

被引:14
|
作者
Cuperus, Nienke [1 ]
van den Hout, Wilbert B. [2 ]
Hoogeboom, Thomas J. [3 ]
van den Hoogen, Frank H. J. [1 ]
Vlieland, Thea P. M. Vliet [2 ]
van den Ende, Cornelia H. M. [1 ]
机构
[1] Sint Maartensklin, Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Maastricht Univ, NL-6200 MD Maastricht, Netherlands
关键词
KNEE OSTEOARTHRITIS; RHEUMATOID-ARTHRITIS; HEALTH; CARE; MANAGEMENT; HIP; RECOMMENDATIONS; TRIAL; RESPONSIVENESS; ECONOMICS;
D O I
10.1002/acr.22709
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To evaluate, from a societal perspective, the cost utility and cost effectiveness of a nonpharmacologic face-to-face treatment program compared with a telephone-based treatment program for patients with generalized osteoarthritis (GOA). Methods. An economic evaluation was carried out alongside a randomized clinical trial involving 147 patients with GOA. Program costs were estimated from time registrations. One-year medical and nonmedical costs were estimated using cost questionnaires. Quality-adjusted life years (QALYs) were estimated using the EuroQol (EQ) classification system, EQ rating scale, and the Short Form 6D (SF-6D). Daily function was measured using the Health Assessment Questionnaire (HAQ) disability index (DI). Cost and QALY/effect differences were analyzed using multilevel regression analysis and cost-effectiveness acceptability curves. Results. Medical costs of the face-to-face treatment and telephone-based treatment were estimated at (sic)387 and (sic)252, respectively. The difference in total societal costs was nonsignificantly in favor of the face-to-face program (difference (sic)708; 95% confidence interval [95% CI] -(sic)5,058, (sic)3,642). QALYs were similar for both groups according to the EQ, but were significantly in favor of the face-to-face group, according to the SF-6D (difference 0.022 [95% CI 0.000, 0.045]). Daily function was similar according to the HAQ DI. Since both societal costs and QALYs/effects were in favor of the face-to-face program, the economic assessment favored this program, regardless of society's willingness to pay. There was a 65-90% chance that the face-to-face program had better cost utility and a 60-70% chance of being cost effective. Conclusion. This economic evaluation from a societal perspective showed that a nonpharmacologic, face-to-face treatment program for patients with GOA was likely to be cost effective, relative to a telephone-based program.
引用
收藏
页码:502 / 510
页数:9
相关论文
共 44 条
  • [21] Effectiveness and Cost-Effectiveness of a Stratified Blended Physiotherapy Intervention Compared With Face-to-Face Physiotherapy in Patients With Nonspecific Low Back Pain: Cluster Randomized Controlled Trial
    Koppenaal, Tjarco
    Dongen, Johanna M. van
    Kloek, Corelien J. J.
    Arensman, Remco M.
    Veenhof, Cindy
    Pisters, Martijn F.
    Ostelo, Raymond W. J. G.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2023, 25
  • [22] Cost-effectiveness of the mobile application TCApp combined with face-to-face CBT treatment compared to face-to-face CBT treatment alone for patients with an eating disorder: study protocol of a multi-centre randomised controlled trial
    Anastasiadou, Dimitra
    Lupianez-Villanueva, Francisco
    Fauli, Clara
    Cunillera, Jordina Arcal
    Serrano-Troncoso, Eduardo
    BMC PSYCHIATRY, 2018, 18
  • [23] Cost-effectiveness of the mobile application TCApp combined with face-to-face CBT treatment compared to face-to-face CBT treatment alone for patients with an eating disorder: study protocol of a multi-centre randomised controlled trial
    Dimitra Anastasiadou
    Francisco Lupiañez-Villanueva
    Clara Faulí
    Jordina Arcal Cunillera
    Eduardo Serrano-Troncoso
    BMC Psychiatry, 18
  • [24] Cost-effectiveness and cost-utility analyses of a web-based computer-tailored intervention for prevention of binge drinking among Spanish adolescents
    Vargas-Martinez, Ana Magdalena
    Lima-Serrano, Marta
    Trapero-Bertran, Marta
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 (02): : 319 - 335
  • [25] The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis
    Hu, Xingdi
    Wildman, Kingsley P.
    Basu, Subham
    Lin, Peggy L.
    Rowntree, Clare
    Saha, Vaskar
    HEALTH ECONOMICS REVIEW, 2019, 9 (01)
  • [26] The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis
    Xingdi Hu
    Kingsley P. Wildman
    Subham Basu
    Peggy L. Lin
    Clare Rowntree
    Vaskar Saha
    Health Economics Review, 9
  • [27] Cost-utility and cost-effectiveness analyses of a long-term, high-intensity exercise program compared with conventional physical therapy in patients with rheumatoid arthritis
    van den Hout, WB
    de Jong, Z
    Munneke, M
    Hazes, JMW
    Breedveld, FC
    Vlieland, TPMV
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (01): : 39 - 47
  • [28] Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data
    Lin, Senlin
    Ma, Yingyan
    Xu, Yi
    Lu, Lina
    He, Jiangnan
    Zhu, Jianfeng
    Peng, Yajun
    Yu, Tao
    Congdon, Nathan
    Zou, Haidong
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
  • [29] Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses
    Durand-Zaleski, Isabelle
    Ducrocq, Gregory
    Mimouni, Maroua
    Frenkiel, Jerome
    Avendano-Sola, Cristina
    Gonzalez-Juanatey, Jose R.
    Ferrari, Emile
    Lemesle, Gilles
    Puymirat, Etienne
    Berard, Laurence
    Cachanado, Marine
    Arnaiz, Joan Albert
    Martinez-Selles, Manuel
    Silvain, Johanne
    Ariza-Sole, Albert
    Calvo, Gonzalo
    Danchin, Nicolas
    Paco, Sandra
    Drouet, Elodie
    Abergel, Helene
    Rousseau, Alexandra
    Simon, Tabassome
    Steg, Philippe Gabriel
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2023, 9 (02) : 194 - 202
  • [30] Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept
    Moayeri, Foruhar
    Dunt, David
    Hsueh, Ya-Seng
    Doyle, Colleen
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (03) : 331 - 340